Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases
Descrição
Niemann-Pick disease type C (NP-C) is a rare, autosomal recessive, neurodegenerative disease associated with a wide variety of progressive neurological manifestations. Miglustat is indicated for the treatment of progressive neurological manifestations in both adults and children. Since approval in 2009 there has been a vast growth in clinical experience with miglustat. The effectiveness of miglustat has been assessed using a range of measures. Comprehensive review of published data from studies of cellular neuropathological markers and structural neurological indices in the brain, clinical impairment/disability, specific clinical neurological manifestations, and patient survival. Cranial diffusion tensor imaging and magnetic resonance spectroscopy studies have shown reduced levels of choline (a neurodegeneration marker), and choline/N-acetyl aspartate ratio (indicating increased neuronal viability) in the brain during up to 5 years of miglustat therapy, as well as a slowing of reductions in fractional anisotropy (an axonal/myelin integrity marker). A 2-year immunoassay study showed significant reductions in CSF-calbindin during treatment, indicating reduced cerebellar Purkinje cell loss. Magnetic resonance imaging studies have demonstrated a protective effect of miglustat on cerebellar and subcortical structure that correlated with clinical symptom severity. Numerous cohort studies assessing core neurological manifestations (impaired ambulation, manipulation, speech, swallowing, other) using NP-C disability scales indicate neurological stabilization over 2–8 years, with a trend for greater benefits in patients with older (non-infantile) age at neurological onset. A randomized controlled trial and several cohort studies have reported improvements or stabilization of saccadic eye movements during 1–5 years of therapy. Swallowing was also shown to improve/remain stable during the randomized trial (up to 2 years), as well as in long-term observational cohorts (up to 6 years). A meta-analysis of dysphagia – a potent risk factor for aspiration pneumonia and premature death in NP-C – demonstrated a survival benefit with miglustat due to improved/stabilized swallowing function. The effects of miglustat on neurological NP-C manifestations has been assessed using a range of approaches, with benefits ranging from cellular changes in the brain through to visible clinical improvements and improved survival.
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://assets.medlink.com/content/article-media/npmv1b.jpg)
Niemann-Pick disease type C
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1750-1172-5-16/MediaObjects/13023_2009_Article_179_Fig2_HTML.jpg)
Niemann-Pick disease type C Orphanet Journal of Rare Diseases
mRNA Treatment Rescues Niemann–Pick Disease Type C1 in Patient
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13023-023-02804-4/MediaObjects/13023_2023_2804_Fig3_HTML.png)
Effects of miglustat therapy on neurological disorder and survival
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://casereports.bmj.com/content/casereports/2017/bcr-2017-220134/F3.large.jpg)
Patient with Niemann-Pick disease type C: over 20 years' follow-up
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://www.mdpi.com/ijms/ijms-22-06600/article_deploy/html/images/ijms-22-06600-g004-550.jpg)
IJMS, Free Full-Text
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fcddis.2016.16/MediaObjects/41419_2016_Article_BFcddis201616_Fig1_HTML.jpg)
Necroptosis in Niemann–Pick disease, type C1: a potential
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13023-022-02200-4/MediaObjects/13023_2022_2200_Fig4_HTML.png)
Clinical disease characteristics of patients with Niemann-Pick
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-06112-y/MediaObjects/41598_2022_6112_Fig1_HTML.png)
Correlation of age of onset and clinical severity in Niemann–Pick
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://ars.els-cdn.com/content/image/1-s2.0-S0022227520353062-gr1.jpg)
Identification of Niemann-Pick C1 disease biomarkers through
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://d3i71xaburhd42.cloudfront.net/903403ed7f2ca16be5230ab0ced49505dc4bf967/3-Table1-1.png)
PDF] Miglustat for treatment of Niemann-Pick C disease: a
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11096-022-01491-8/MediaObjects/11096_2022_1491_Fig2_HTML.png)
Cost-effectiveness of miglustat versus symptomatic therapy of
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://media.springernature.com/lw400/springer-static/cover/journal/13023/16/1.jpg?as=jpg)
Validation of the 5-domain Niemann-Pick type C Clinical Severity
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://europepmc.org/articles/PMC8842861/bin/13023_2022_2200_Fig1_HTML.jpg)
Clinical disease characteristics of patients with Niemann-Pick
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://onlinelibrary.wiley.com/cms/asset/cb4188d2-a449-4117-93fc-397140fe7a12/jnc14895-fig-0003-m.jpg)
Niemann–Pick type C disease: cellular pathology and
de
por adulto (o preço varia de acordo com o tamanho do grupo)